RxDoctor Payments Data

Benjamin Mills, DO

Internal Medicine · Jonesboro, ARNPI 1477119543

Payments from drug & device makers

$576in general payments, 2019–2025

Across 36 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$188
  • GSK$90
  • Sumitomo Pharma America, Inc.$41
  • Medtronic$37
  • Bayer$32
  • Lilly USA, LLC$27
  • plus $160 from 10 others

What the payments were for

  • Food & beverage$576100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$576 in reported general payments places this provider in the 65th percentile of 614 internal medicine providers in Arkansas.

See all internal medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$251,909
Medicare patients
759
Services billed
6,433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide149$175,131
EliquisApixaban209$152,660
MounjaroTirzepatide131$152,182
JardianceEmpagliflozin129$126,123
TrulicityDulaglutide63$80,799
Trelegy ElliptaFluticasone/Umeclidin/Vilanter95$71,655
XareltoRivaroxaban56$46,990
JanuviaSitagliptin Phosphate36$29,003
FarxigaDapagliflozin Propanediol30$28,861
LinzessLinaclotide26$25,825
EntrestoSacubitril/Valsartan35$25,344
Repatha SureclickEvolocumab22$19,126
GlyxambiEmpagliflozin/Linagliptin17$15,847
MyrbetriqMirabegron22$15,142
Tresiba Flextouch U-200Insulin Degludec16$13,486

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$27$232,981194 claims
Novo NordiskOzempic$14$175,131149 claims
PfizerEliquis$27$152,660209 claims
Boehringer IngelheimJardiance, Glyxambi$17$141,969146 claims
GSKTrelegy Ellipta$90$71,65595 claims
MerckJanuvia, Belsomra$15$41,77354 claims
AbbVieLinzess, Synthroid$188$28,58570 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 614 internal medicine providers in Arkansas.

Other internal medicine in Jonesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →